Ref: When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab. 2019 Jun;21(6):1305-1310.
Ref: When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab. 2019 Jun;21(6):1305-1310.
Ref: Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2291-2301.
Ref: Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2291-2301.
Ref: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.
Ref: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.
Ref: Association of Sugary Beverage Consumption With Mortality Risk in US Adults: A Secondary Analysis of Data From the REGARDS Study. JAMA Netw Open. 2019 May 3;2(5):e193121.
8 min
About SBD
From the publisher's feed
Acompanhe as últimas novidades sobre o diabetes, tratamentos e muito mais, com os Podcasts da Sociedade Brasileira de Diabetes, exclusivos para profissionais da saúde.
Os programas contarão com a participação de grandes diabetologistas brasileiros, comentando artigos nacionais e internacionais, para que você esteja sempre bem informado sobre as últimas tendências.